Jefferson Kinney, PhD


Assessing, Validating Clinically Relevant Biomarkers for Alzheimer Disease: Jefferson Kinney, PhD

The founding chair of the department of brain health at the University of Nevada Las Vegas discussed the plethora of Alzheimer disease biomarkers and the need for consensus on the value of each. [WATCH TIME: 3 minutes]

Frederic Schaper, MD, PhD


Takotsubo Syndrome and the Brain-Heart Connection: Frederic Schaper, MD, PhD

The instructor in neurology at Brigham and Women's Hospital talked about research exploring takotsubo syndrome, a heart condition often triggered by emotional or physical stressors, and its relationship with brain lesions. [WATCH TIME: 5 minutes]

Laurie Gutmann, MD


AUPN 2022 Women Leaders in Neurology

Laurie Gutmann, MD; Gauri Pawar, MD; and Claire Henchcliffe, MD, discuss their own paths in medicine and observations of other women leaders. [WATCH TIME: 1 hour, 51 minutes]

Julie Silver, MD


AUPN Leadership Minute Episode 30: Pay and Promotion Disparities and Maintaining Equity

Episode 30 of the AUPN Leadership Minute features Rohit Das, MD, of UT Southwestern Medical Center; and Julie Silver, MD, of Harvard Medical School. [WATCH TIME: 8 minutes]

Robert A. Hauser, MD, MBA


Widening the Therapeutic Window in The Management of Parkinson’s Disease

Expert neurologists discuss strategies to widen the therapeutic window of Parkinson’s disease and options available to treat dyskinesia, providing better control of Parkinson’s disease.

Paul Fisher, MD


Stanford Children’s Health: A Comprehensive Approach to Care for a Child With a Neurological Condition

Physicians from Stanford Children’s Health offer their keys to successful pediatric neuroscience teams and what to focus on to provide a better quality of life for children.

Chengyuan Wu, MD, MSBmE


Roundtable: The Future of Stereotactic and Functional Neurosurgery

Two experts at Jefferson Health discuss several topics related to advances in neurosurgery, technology, and the future of minimally invasive procedures.

Eric P. Hoffman, PhD


Future of Treating DMD

Final thoughts from leading experts on the future of treating Duchenne muscular dystrophy and keeping standard of care in the forefront.

Brandon Brown, PharmD


Quality of Life and Treatment Satisfaction With Disease-Modifying Therapies

Jason Freeman, MD, MBA, and Brandon Brown, PharmD, discuss the poster “Quality of Life and Treatment Satisfaction With Disease-Modifying Therapies in Multiple Sclerosis” presented at ACTRIMS 2023. Sponsored By Novartis.

Marcelo Kerstenetzky, MD


Key Considerations in Treatment of Spinal Muscular Atrophy / Considerações essenciais para o tratamento da atrofia muscular espinhal

The expert panel shares clinical pearls for treatment and management of Spinal Muscular Atrophy. O painel de especialistas compartilha recomendações valiosas para o tratamento e manejo da atrofia muscular espinhal.

Donald Whiting, MD


Exploring Deep Brain Stimulation’s Effects in Alzheimer Disease: Donald Whiting, MD

The chair of Allegheny Health Network’s Neurosciences Institute discussed a groundbreaking phase 3 trial evaluating the safety and efficacy of deep brain stimulation in patients with Alzheimer disease. [WATCH TIME: 5 minutes]

Blake E. Dewey, PhD


Expanding the Use of Spinal Cord Atrophy in Multiple Sclerosis: Blake E. Dewey, PhD

The postdoctoral researcher at the Johns Hopkins Multiple Sclerosis Center shared his perspective on the use of spinal cord atrophy in clinical practice to measure disease progression in MS and how it might become more accessible. [WATCH TIME: 4 minutes]

Theresa Sevilis, DO


Taking the Leap: Forging Your Own Path as a Woman in Medicine

Theresa Sevilis, DO, writes on picking a career path in medicine as a woman, and how deciding to jump ship from a traditional path was among the best decisions she's made.

Selim R. Benbadis, MD, FAAN, FACNS, FAES


AUPN Leadership Minute Episode 16: Turning Your Clinic Into a Source of Scholarly Activity

Episode 16 of the AUPN Leadership Minute features Rohit Das, MD, of UT Southwestern Medical Center; and Selim R. Benbadis, MD, FAAN, FACNS, FAES, University of South Florida Morsani College of Medicine. [WATCH TIME: 4 minutes]

Stephen Samples, MD


Lessons in Migraine Medicine and Changes to the Treatment Toolbox: Stephen Samples, MD

The chair of Allegheny Health Network’s department of neurology provided insight on his clinical experiences with migraine medicine and how the field needs to adapt to the ongoing changes to treatment options. [WATCH TIME: 4 minutes]

A. Gordon Smith, MD, FAAN


Neurologist’s Role in Addressing Healthcare Disparities: A. Gordon Smith, MD, FAAN

The professor and chair of neurology at Virginia Commonwealth University discussed how neurologists are urged to take organized action and provide training on healthcare disparities, with a particular focus on race, ethnicity, and financial barriers to access. [WATCH TIME: 2 minutes]

Charles Bernick, MD


Role of Fluid Biomarkers and GFAP in Neurodegeneration: Charles Bernick, MD

The neurologist at Cleveland Clinic provided perspective on the reasons to study individuals exposed to repetitive head impacts and the lessons learned about monitoring glial fibrillary acidic protein over time. [WATCH TIME: 4 minutes]

Stephen Peroutka, MD


PPD/TFS Fostering Global Awareness in Rare Disorders

Rare Disease Day raises awareness for rare disorders, highlighting challenges, improving detection, and fostering collaboration for treatment advancements.

Donovan Lott, PT, PhD, CSCS


Maximizing Exercise as Movement Medicine for Neuromuscular Diseases: Donovan Lott, PT, PhD, CSCS

The research associate professor in the department of physical therapy at the University of Florida talked about physical therapy inventions for neuromuscular diseases at the 2023 MDA conference. [WATCH TIME: 4 minutes]

Olga Thon, MD


New Horizons in Multiple Sclerosis

Experts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.

Thomas Crawford, MD


Managing Clinical Stability in Adults Spinal Muscular Atrophy Patients

Clinical experts in spinal muscular atrophy (SMA) address the issue of patient disengagement from healthcare services, which can occur due to a perceived lack of disease progression or stabilization, leading to undetected disease advancement and increased risk to patients, and provide recommendations for encouraging patients to re-engage with medical care.

Jacqueline Glascock, PhD


2022 SMA Research & Clinical Care Meeting: What to Expect

Mary Schroth, MD, and Jacqueline Glascock, PhD, of Cure SMA, share their perspectives on the upcoming annual meeting.

Jeannette R. Mahoney, PhD


Digital Health Tool Offers Innovative Quantitative Fall Assessment Solution for Older Adults

Falls cost the US more than $50 billion annually, but platforms like CatchU, a transformative digital health tool, provide quantitative fall assessment that might significantly enhance the current standard of care for predicting falls.

Alistair Mackett, MD


The Future of Parkinson Disease Treatment With Innovative Wearable Devices: Alistair Mackett, MD

The movement disorder specialist at Cambridge University Hospitals NHS Foundation Trust discussed the rise of wearable technology for managing Parkinson disease to potentially empower patients and monitor the disease at early stages. [WATCH TIME: 4 minutes]

Anne H. Cross, MD


Shifting to a Collaborative Approach to Conquer Challenges in Progressive MS: Anne H. Cross, MD

The professor of neurology at Washington University School of Medicine discussed the growing sense of hope among patients with progressive multiple sclerosis as providers gain an understanding in treating this form of the disease. [WATCH TIME: 3 minutes]

Kari Rosbeck


TSC Alliance’s Growth Has Led to Improved Lives and Progress Toward a Cure

In light of Tuberous Sclerosis Complex (TSC) Awareness Month throughout May, Kari Rosbeck, president and CEO, TSC Alliance, highlights what has been done to advance TSC research and how the organization is improving the diagnosis journey, access to care, and support for families.

Claude Steriade, MD, CM


Epilepsy Awareness and First Aid for Seizures in 2024: Claude Steriade, MD, CM

The epileptologist at NYU Langone Health and associate professor of neurology at NYU Grossman School of Medicine talked about the ongoing need to improve public awareness and education on seizure first aid. [WATCH TIME: 3 minutes]

Konstantin Karmazin, MD


Future Plans, Goals for Prime PD: Konstantin Karmazin, MD

The chief medical officer of Prime PD, a new digital wellness studio for patients with Parkinson disease, detailed future initiatives for the platform. [WATCH TIME: 4 minutes]

Christopher Elder, MD


Recommendations for Treating Epilepsy in the Clinical Space: Christopher Elder, MD

The clinical assistant professor of neurology in the Comprehensive Epilepsy Center at NYU Langone Health gives recommendations for clinical care on prescribed antiseizure medication and RNA therapy. [WATCH TIME: 5 minutes]

George Grossberg, MD


Assessing Potential Treatment Options for Agitation in Older Adults With Alzheimer Disease: George Grossberg, MD

The director of Geriatric Psychiatry at the St Louis University School of Medicine talked about BXCL501 as a potential treatment for acute agitation in patients with Alzheimer disease and how it compares with brexpiprazole, the first approved therapy. [WATCH TIME: 4 minutes]

© 2024 MJH Life Sciences

All rights reserved.